2022 Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Rama Al Hamed Journal Cancer Med.
2022 Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2022 Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Christoph Schmid Journal Bone Marrow Transplant.
2022 The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML Group Acute Leukemia Working Party (ALWP) 1st listed author Avichai Shimoni Journal Bone Marrow Transplant.
2022 Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Transplant Cell Ther.
2022 Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement Group Paediatric Diseases Working Party (PDWP) Other society 1st listed author Matteo Di Nardo Journal Lancet Child Adolesc Health.
2022 Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia Group Infectious Diseases Working Party (IDWP) 1st listed author Anne Bergeron Journal Lancet Infect Dis.
2022 Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Jan Styczynski Journal Transpl Infect Dis.
2022 How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Antonio Maria Risitano Journal Br J Haematol.
2022 High-dose immunosuppressive therapy with autologous hematopoietic stem cells transplantation for multiple sclerosis: Current view Group Autoimmune Diseases Working Party (ADWP) 1st listed author Alexey Yu. Polushin Journal Cellular Therapy and Transplantation (CTT).
2022 Is stem cell transplantation safe and effective in multiple sclerosis? Group Autoimmune Diseases Working Party (ADWP) 1st listed author Basil Sharrack Journal BMJ.
2022 Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches Group Autoimmune Diseases Working Party (ADWP) 1st listed author Elisabetta Xue Journal Cells.